DeepCast LogoDeepCast Full Wordmark

Topic: Alzheimer's treatment

The FDA has recently approved a new drug called Kissenale and Danamab for the treatment of early Alzheimer's disease, providing a new option for patients.

More on: Alzheimer's treatment

The podcast episodes mention the FDA's approval of new drugs for the treatment of Alzheimer's disease, which is a significant development in the field of Alzheimer's research and treatment.

In the first episode, the topic of the FDA's approval of a new drug called Kissenale is briefly mentioned, while the second episode focuses more on the approval of a different drug called Danamab and its potential benefits and cost.

These episodes provide important information and context around the latest advancements in Alzheimer's treatment, which is a critical issue for many older adults and their families.

All Episodes